Streetbeat News

NANX

Nanophase Technologies Corp.

Employees

58

Industry

All Other Basic Organic Chemical Manufacturing

Open

2.33

Mkt cap

181M

Volume

6.2K

High

2.62

P/E Ratio

64.50

52-wk high

3.15

Low

2.45

Div yield

N/A

52-wk low

0.40

Nanophase Technologies is poised for growth with double-digit revenue increases and profitability. The company has resolved its legal issues and improved margins, making it an attractive investment despite limited trading volume.

Portfolio Pulse from

January 17, 2025 | 4:00 am

Nanophase Technologies reported a significant improvement in its Q3 financial results, with GAAP EPS rising to $0.04 from a loss of $(0.03) per share year-over-year, and sales increasing by 111.94% to $16.87 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:04 pm

Insider buying activity has been observed in three penny stocks: Roadzen, System1, and Nanophase Technologies. This could indicate confidence in these companies' prospects. Roadzen reported a quarterly loss, System1 posted strong earnings, and Nanophase saw increased sales.

Portfolio Pulse from Avi Kapoor

September 10, 2024 | 11:28 am

Insider buying activity was noted in several penny stocks, including Cyanotech, Emeren Group, Red Robin Gourmet Burgers, and Nanophase Technologies. Such transactions can indicate insider confidence in the company's prospects.

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 11:29 am

Insider buying activity has been observed in three penny stocks: Nanophase Technologies, Alset Inc., and CPI Aerostructures. This insider activity may indicate confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

August 23, 2024 | 11:25 am

Nanophase Technologies reported Q2 earnings per share (EPS) of $0.01, unchanged from the same period last year. The company saw a 9.89% increase in sales, reaching $13.05 million compared to $11.87 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:40 pm

The article highlights recent insider transactions in three penny stocks: Nanophase Technologies, Nuvation Bio, and NeuroBo Pharmaceuticals. Insider buying can indicate confidence in the company's prospects.

Portfolio Pulse from Avi Kapoor

June 26, 2024 | 12:48 pm

The article discusses recent insider transactions in penny stocks, highlighting purchases by executives at Kronos Bio, Assertio Holdings, and Nanophase Technologies. These transactions may indicate confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

June 13, 2024 | 1:10 pm

The article highlights notable insider transactions in penny stocks, including Crexendo, Retractable Technologies, Aurora Innovation, Telos, and Nanophase Technologies. These transactions indicate insider confidence in these companies' prospects.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 10:57 am

Insiders are buying shares in Zomedica, Earth Science Tech, Nanophase Technologies, and Cerus, indicating potential confidence in these companies. Notable transactions include purchases by directors and CEOs at prices below $3, with Zomedica's CEO acquiring 100,000 shares. Earth Science Tech announced a stock repurchase program, Nanophase Technologies reported Q1 financial results, Cerus reported increased product revenue, and Zomedica reported a decrease in GAAP EPS and worse-than-expected sales.

Portfolio Pulse from Avi Kapoor

May 14, 2024 | 1:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.